Form 4: VolitionRx General Counsel Nicholas Plummer Awarded Restricted Stock Units in Lieu of Cash Compensation

VolitionRx Ltd. General Counsel Nicholas Plummer was awarded 16,086 restricted stock units as part of his compensation, vesting in three installments through August 2025.

Summary

• Nicholas Plummer, General Counsel of Volition Diagnostics, a subsidiary of VolitionRx Ltd. (VNRX), was awarded 16,086 restricted stock units (RSUs).
• The RSUs were granted on June 1, 2025, under the Issuer's 2015 Stock Incentive Plan.
• This award was made in lieu of cash compensation that would otherwise have been owed to Mr. Plummer.
• The RSUs will vest in three equal installments of 5,362 units on June 1, 2025, July 1, 2025, and August 1, 2025.
• Vesting is contingent upon continued service throughout each applicable vesting date.
• Upon vesting and settlement, Mr. Plummer will receive shares of common stock equal to the number of vested RSUs.
• Following this transaction, Mr. Plummer beneficially owns 193,714 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates executive compensation and alignment of interests, which is a normal and often beneficial corporate action. It's not highly impactful but generally viewed as a positive for executive retention and motivation.

Positives

• The award of 16,086 restricted stock units to General Counsel Nicholas Plummer aligns his interests with shareholders.
• The use of restricted stock units in lieu of cash compensation can help conserve cash for the company.

Risks

• The vesting of the restricted stock units is subject to continued service, meaning the executive must remain employed to receive the full award.

Future Outlook

The awarded restricted stock units are scheduled to vest in three equal installments on June 1, 2025, July 1, 2025, and August 1, 2025, contingent on continued service.

Industry Context

This Form 4 filing represents a routine insider transaction, specifically an executive compensation award, which is a common practice across industries to align management incentives with shareholder interests. Such awards are typically part of a broader compensation strategy.

Corporate Governance

Related Party Transactions

• Nicholas Plummer, General Counsel of Volition Diagnostics (a subsidiary of VolitionRx Ltd.), received 16,086 restricted stock units as compensation, which is a transaction between the company and a key executive.

Stakeholder Impact

• Shareholders: The award of RSUs aligns the executive's interests with shareholders by tying compensation to stock performance.
• Employees: No direct impact on general employees is indicated by this filing.
• Executive (Nicholas Plummer): Directly benefits from the RSU award as part of his compensation.

Next Steps

• The vesting and subsequent settlement of the restricted stock units into common stock on June 1, 2025, July 1, 2025, and August 1, 2025.

Key Dates

Keywords

VolitionRx, VNRX, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Executive Compensation, Stock Incentive Plan, Nicholas Plummer, Corporate Governance